Nav: Home

Here comes 'NoBody,' a microprotein on a mission

December 05, 2016

New Haven, Conn. - Yale researchers have helped identify a novel, functional "microprotein" encoded in the human genome, using a technique that has revealed more than 400 new proteins too tiny to be found by other means.

One of those microproteins, called NoBody, is a molecular workhorse involved in sweeping out unneeded genetic material inside cells. Its discovery may signal the existence of additional microproteins involved in a host of key biological mechanisms and diseases, the researchers said.

"The broadest significance of this work is that even in a well-studied biological process, a microprotein has been right there under our noses, undetected, all this time," said Sarah Slavoff, co-senior author of a study published Dec. 5 in the journal Nature Chemical Biology.

Slavoff is an assistant professor of chemistry and of molecular biophysics and biochemistry at Yale. She is a member of the Chemical Biology Institute at Yale's West Campus.

The study's first author is Nadia D'Lima, a researcher in Slavoff's lab. Alan Saghatelian of the Salk Institute for Biological Studies is the study's other co-senior author.

"Despite how much we know about the human genome, there are still blind spots in the genome discovery algorithms," Saghatelian said. "You can sequence the whole human genome and never know a protein, like this one, was there because it's too short and falls below the usual length requirement for gene assignment algorithms."

In previous work, the researchers began their search for microproteins by examining myeloid leukemia cells and removing the larger proteins. They used an analytical chemistry technique, liquid chromatography-mass spectroscopy proteomics, to find the amino acid sequences of every remaining protein.

Next, the researchers developed a computational method to build a database of all possible microproteins in the sample. From this database, Slavoff and her colleagues found more than 400 new microproteins.

The study focused on a microprotein called NoBody, which stands for non-annotated P-body dissociating polypeptide. The researchers found that NoBody is a key ingredient in cells for recycling mRNA -- genetic blueprints for producing proteins -- after those proteins have been created.

Slavoff said the finding hints that microproteins may play important roles in many biological processes, as well as disease. There are many neurological diseases, for example, that feature groupings of proteins.
-end-
Additional authors of the study included Lauren Winkler of Yale, Jiao Ma and Qian Chu of the Salk Institute, Ken H. Loh of the Massachusetts Institute of Technology, Elizabeth O. Corpuz and Jens Lykke-Anderson of the University of California-San Diego, and Bogdan A. Budnik of Harvard.

The research was funded by a George E. Hewitt Foundation for Medical Research postdoctoral fellowship, the National Institutes of Health, the Leona M. and Harry B. Helmsley Charitable Trust, and Dr. Frederik Paulsen Chair/Ferring Pharmaceuticals.

Yale University

Related Human Genome Articles:

It's in our genome: Uncovering clues to longevity from human genetics
Researchers from Osaka University found that high blood pressure and obesity are the strongest factors reducing lifespan based on genetic and clinical information of 700,000 patients in the UK, Finland and Japan.
Scientists generate an atlas of the human genome using stem cells
Scientists from the Hebrew University of Jerusalem have generated an atlas of the human genome that illuminates the roles our genes play in health and disease.
New limits to functional portion of human genome reported
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.
Synthesizing the human genome from scratch
For the past 15 years, synthetic biologists have been figuring out how to synthesize an organism's complete set of DNA, including all of its genes.
Science and legal experts debate future uses and impact of human genome editing in Gender & the Genome
Precise, economical genome editing tools such as CRISPR have made it possible to make targeted changes in genes, which could be applied to human embryos to correct mutations, prevent disease, or alter traits.
Evolution purged many Neanderthal genes from human genome
Neanderthal genetic material is found in only small amounts in the genomes of modern humans because, after interbreeding, natural selection removed large numbers of weakly deleterious Neanderthal gene variants, according to a study by Ivan Juric and colleagues at the University of California, Davis, published Nov.
Mathematical analysis reveals architecture of the human genome
Mathematical analysis has led researchers in Japan to a formula that can describe the movement of DNA inside living human cells.
Navigating the human genome with Sequins
Australian genomics researchers have announced the development of Sequins -- synthetic 'mirror' DNA sequences that reflect the human genome.
Scientists cut 'Gordian knot' in the human genome
Females have two X chromosomes in each of their cells.
Guidelines for human genome editing
As countries around the world seek to craft policy frameworks governing the powerful new genetic editing tool, policy makers need to determine 'thresholds of acceptability' for using the technology, according to three researchers from the Centre of Genomics and Policy at McGill University.
More Human Genome News and Human Genome Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.